Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers

Hadrup, Sine Reker, Bakker, Arnold H, Shu, Chengyi J, Andersen, Rikke S, van Veluw, Jerre, Hombrink, Pleun, Castermans, Emilie, thor Straten, Per +4 more·2009·Nature Methods

Cited by (307)

Items 101–200 of 307

  1. T-Cell Receptor Gene Therapy: Critical Parameters for Clinical Success
    Carsten Linnemann, Ton N. Schumacher, Gavin M. Bendle · 2011 · Journal of Investigative Dermatology
  2. Gene Expression-Based Identification of Antigen-Responsive CD8+ T Cells on a Single-Cell Level
    Yannick F. Fuchs, Virag Sharma, Anne Eugster, Gloria Kraus, Robert Morgenstern, Andreas Dahl, Susanne Reinhardt, Andreas Petzold, Annett Lindner, Doreen Löbel et al. · 2019 · Frontiers in Immunology
  3. Combination of targeted therapy and immunotherapy in melanoma
    Christian U. Blank, Anna I. Hooijkaas, John B.A.G. Haanen, Ton N. Schumacher · 2011 · Cancer Immunology Immunotherapy
  4. Multimer technologies for detection and adoptive transfer of antigen-specific T cells
    Rosaely Casalegno‐Garduño, Anita Schmitt, Junxia Yao, Xinchao Wang, Xun Xu, Mathias Freund, Michael W. Schmitt · 2009 · Cancer Immunology Immunotherapy
  5. Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
    Yue Zheng, Yang Fu, Peipei Wang, Zhenyu Ding · 2022 · Disease Markers
  6. Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response
    Anastasia Gangaev, Elisa A. Rozeman, Maartje W. Rohaan, Olga I. Isaeva, Daisy Philips, Sanne Patiwael, Joost H. van den Berg, Antoni Ribas, Dirk Schadendorf, Bastian Schilling et al. · 2021 · Proceedings of the National Academy of Sciences
  7. A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
    Eirini Giannakopoulou, Madeleine Lehander, Stina Virding Culleton, Weiwen Yang, Yingqian Li, Terhi Kärpänen, Tetsuichi Yoshizato, Even Holth Rustad, Morten Milek Nielsen, Ravi Chand Bollineni et al. · 2023 · Nature Cancer
  8. A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells
    Marleen M. van Loenen, Renate de Boer, Ellis van Liempt, Pauline Meij, Inge Jedema, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk · 2013 · Haematologica
  9. Analysis, Isolation, and Activation of Antigen-Specific CD4+ and CD8+ T Cells by Soluble MHC-Peptide Complexes
    Julien Schmidt, Danijel Dojcinovic, Philippe Guillaume, Immanuel F. Luescher · 2013 · Frontiers in Immunology
  10. Peripheral and systemic antigens elicit an expandable pool of resident memory CD8 <sup>+</sup> T cells in the bone marrow
    Pascutti, Maria Fernanda, Geerman, Sulima, Collins, Nicholas, Brasser, Giso, Nota, Benjamin, Stark, Regina, Behr, Felix, Oja, Anna, Slot, Edith, Panagioti, Eleni et al. · 2019 · European Journal of Immunology
  11. Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection.
    A. Gehring, Patricia Mendez, Kirsten Richter, H. Ertl, Eric F. Donaldson, P. Mishra, M. Maini, A. Boonstra, G. Lauer, A. de Creus et al. · 2022 · Journal of Hepatology
  12. T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
    Muhammad Ali, Eirini Giannakopoulou, Yingqian Li, Madeleine Lehander, Stina Virding Culleton, Weiwen Yang, Cathrine F. Knetter, Mete Can Odabasi, Ravi Chand Bollineni, Xinbo Yang et al. · 2021 · Nature Biotechnology
  13. Human cancer regression antigens
    Pia Kvistborg, Marit M. van Buuren, Ton N. Schumacher · 2013 · Current Opinion in Immunology
  14. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
    Siwen Hu‐Lieskovan, Srabani Bhaumik, Kavita M. Dhodapkar, Jean‐Charles Grivel, Sumati V. Gupta, Brent Allen Hanks, Sylvia Janetzki, Thomas O. Kleen, Yoshinobu Koguchi, Amanda W. Lund et al. · 2020 · Journal for ImmunoTherapy of Cancer
  15. Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies
    Florian Kast, Christian Klein, Pablo Umaña, Alena Gros, Stephan Gasser · 2021 · OncoImmunology
  16. Mixed functional characteristics correlating with TCR ‐ligand koff‐rate of MHC ‐tetramer reactive T cells within the naive T ‐cell repertoire
    Pleun Hombrink, Yotam Raz, Michel G.D. Kester, Renate de Boer, Bianca Weißbrich, Peter A. von dem Borne, Dirk Hans Busch, Ton N. Schumacher, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk · 2013 · European Journal of Immunology
  17. Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes
    Shraddha Kumari, Sébastien Wälchli, Lars-Egil Fallang, Weiwen Yang, Fridtjof Lund‐Johansen, Ton N. Schumacher, Johanna Olweus · 2013 · Proceedings of the National Academy of Sciences
  18. Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma
    Sofie Kirial Mørk, Signe K. Skadborg, Benedetta Albieri, Arianna Draghi, Kalijn F. Bol, Mohammad Kadivar, Marie Christine Wulff Westergaard, Joachim Stoltenborg Granhøj, Annie Borch, Nadia Viborg et al. · 2024 · Journal for ImmunoTherapy of Cancer
  19. High-Throughput Identification of Potential Minor Histocompatibility Antigens by MHC Tetramer-Based Screening: Feasibility and Limitations
    Pleun Hombrink, Sine Reker Hadrup, Arne Bakker, Michel G.D. Kester, J.H. Frederik Falkenburg, Peter A. von dem Borne, Ton N. Schumacher, Mirjam H.M. Heemskerk · 2011 · PLoS ONE
  20. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy
    Morten Hansen, Gertrud M. Hjortø, Marco Donia, Özcan Met, Niels B. Larsen, Mads Hald Andersen, Per thor Straten, Inge Marie Svane · 2012 · Vaccine
  21. Discovery of T Cell Epitopes Implementing HLA-Peptidomics into a Reverse Immunology Approach
    Pleun Hombrink, Chopie Hassan, Michel G.D. Kester, Arnoud H. de Ru, Cornelis A.M. van Bergen, Harm Nijveen, Jan Wouter Drijfhout, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk, Peter A. van Veelen · 2013 · The Journal of Immunology
  22. Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer
    Mads Duus Hjortsø, Stine Kiær Larsen, Per Kongsted, Özcan Met, Thomas Mørch Frøsig, Gitte Holmen Olofsson, Shamaila Munir Ahmad, Inge Marie Svane, Jürgen Christian Becker, Per thor Straten et al. · 2014 · OncoImmunology
  23. Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
    Trine Zeeberg Iversen, Marie Klinge Brimnes, Kirsten Nikolajsen, Rikke Sick Andersen, Sine Reker Hadrup, Mads Hald Andersen, Lars Bastholt, Inge Marie Svane · 2013 · OncoImmunology
  24. Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
    Jon Bjoern, Rikke Lyngaa, Rikke Sick Andersen, Lisbet Rosenkrantz Hölmich, Sine Reker Hadrup, Marco Donia, Inge Marie Svane · 2017 · Oncotarget
  25. MHC-based detection of antigen-specific CD8+ T cell responses
    Sine Reker Hadrup, Ton N. Schumacher · 2010 · Cancer Immunology Immunotherapy
  26. Flow cytometry‐based TCR‐ligand Koff‐rate assay for fast avidity screening of even very small antigen‐specific T cell populations ex vivo
    Magdalena Nauerth, Christian Stemberger, Fabian Mohr, Bianca Weißbrich, Matthias Schiemann, Lothar Germeroth, Dirk Hans Busch · 2016 · Cytometry Part A
  27. Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage
    Celia R. Berkers, Annemieke de Jong, Karianne G. Schuurman, Carsten Linnemann, Jan A. J. Geenevasen, Ton N. Schumacher, Boris Rodenko, Huib Ovaa · 2015 · The Journal of Immunology
  28. Preparation of Peptide–MHC and T-cell Receptor Dextramers by Biotinylated Dextran Doping
    Michael T. Bethune, Begoña Comı́n-Anduix, Yu-Hsien Hwang Fu, Antoni Ribas, David Baltimore · 2017 · BioTechniques
  29. Translation dysregulation in cancer as a source for targetable antigens
    Chen Weller, Osnat Bartok, Christopher S. McGinnis, Heyilimu Palashati, Tiangen Chang, Dmitry B. Malko, Merav D. Shmueli, Asuteka Nagao, Déborah Hayoun, Ayaka Murayama et al. · 2025 · Cancer Cell
  30. Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens
    An M. T. Van Nuffel, Sandra Tuyaerts, Daphné Benteyn, Sofie Wilgenhof, Jurgen Corthals, Carlo Heirman, Bart Neyns, Kris Thielemans, Aude Bonehill · 2012 · Journal of Immunological Methods
  31. Alternative splicing and differential expression of the islet autoantigen IGRP between pancreas and thymus contributes to immunogenicity of pancreatic islets but not diabetogenicity in humans
    V. Martijn de Jong, Joana R. F. Abreu, A. A. Verrijn Stuart, Arno R. van der Slik, Katrijn Verhaeghen, Marten A. Engelse, Bianca Blom, Frank J. T. Staal, Frans Gorus, Bart O. Roep · 2013 · Diabetologia
  32. Antigen‐specific and cross‐reactive T cells in protection and disease
    Ning Jenny Jiang, Michael D. Malone, Shahab Chizari · 2023 · Immunological Reviews
  33. The potential of multimer technologies in type 1 diabetes prediction strategies
    Alessandra Fierabracci · 2010 · Diabetes/Metabolism Research and Reviews
  34. Identification of Immunogenic Epitopes by MS/MS
    Moreno Di Marco, Janet K. Peper-Gabriel, Hans‐Georg Rammensee · 2017 · The Cancer Journal
  35. Adaptive Nanoparticle Platforms for High Throughput Expansion and Detection of Antigen-Specific T cells
    John W. Hickey, Ariel Isser, Sebastian F. Salathe, Kayla M. Gee, Meng-Hsuan Hsiao, Wasamah Shaikh, Nkechi C. Uzoukwu, Joan Glick Bieler, Hai‐Quan Mao, Jonathan P. Schneck · 2020 · Nano Letters
  36. Cancer–germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment
    Morten F. Gjerstorff, Jorge Sans Burns, Henrik J. Ditzel · 2010 · Expert Opinion on Biological Therapy
  37. Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma
    Julie S. Nielsen, Andrew Chang, Darin A. Wick, Colin G. Sedgwick, Zusheng Zong, Andrew J. J. Mungall, Spencer D. Martin, Natalie N. Kinloch, Susann Ott-Langer, Zabrina L. Brumme et al. · 2017 · OncoImmunology
  38. FLEXamers: A Double Tag for Universal Generation of Versatile Peptide-MHC Multimers
    Manuel J. P. Effenberger, Andreas Stengl, Kilian Schober, Maria Gerget, Maximilian Kampick, Thomas R Müller, Dominik Schumacher, Jonas Helma, Heinrich Leonhardt, Dirk Hans Busch · 2019 · The Journal of Immunology
  39. Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer
    Saillard, Margaux, Cenerenti, Mara, Romero, Pedro, Jandus, Camilla · 2021 · Vaccines
  40. Parallel detection of SARS‐CoV ‐2 epitopes reveals dynamic immunodominance profiles of CD8 + T memory cells in convalescent COVID ‐19 donors
    Jet van den Dijssel, Ruth R. Hagen, Rivka de Jongh, Maurice Steenhuis, Theo Rispens, Dionne M. Geerdes, Juk Yee Mok, Angela HM. Kragten, Mariël C Duurland, Niels J. M. Verstegen et al. · 2022 · Clinical & Translational Immunology
  41. Modeling flow cytometry data for cancer vaccine immune monitoring
    Jacob Frelinger, Janet S. Ottinger, Cécile Gouttefangeas, Cliburn C. W. Chan · 2010 · Cancer Immunology Immunotherapy
  42. The Role of Neoantigens in Cancer Immunotherapy
    Yueting Zhu, Jiyan Liu · 2021 · Frontiers in Oncology
  43. Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells
    Sine Reker Hadrup, Dominik Maurer, Karoline Laske, Thomas Mørch Frøsig, Sofie Ramskov, Cedrik Michael Britten, Sjoerd H. van der Burg, Steffen Walter, Cécile Gouttefangeas · 2014 · Cytometry Part A
  44. T-cell epitope discovery technologies
    Govinda Sharma, Robert A. Holt · 2014 · Human Immunology
  45. Combinatorial detection of autoreactive CD8+ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop
    Eddie A. James, Joana R. F. Abreu, John W. McGinty, Jared Odegard, Yvonne E. Fillié, Claire N. Hocter, Slobodan Čulina, Kristin Ladell, David A. Price, Aimon K. Alkanani et al. · 2017 · Diabetologia
  46. Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
    Yicheng Zhu, Youkun Qian, Zhile Li, Yangyang Li, Bin Li · 2021 · MedComm
  47. Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance
    Franziska Füchsl, Angela M. Krackhardt · 2022 · Cells
  48. Antigen-specific T cells and autoimmunity
    Manuel Rojas, Yeny Acosta‐Ampudia, Luke S. Heuer, Weici Zang, Diana M. Monsalve, Carolina Ramı́rez-Santana, Juan‐Manuel Anaya, William M. Ridgway, Aftab Ahmed Ansari, M. Eric Gershwin · 2024 · Journal of Autoimmunity
  49. Adoptive Cellular Therapy (ACT) for Cancer Treatment
    Fan Yang, Hao Jin, Jian Wang, Qian Sun, Cihui Yan, Feng Wei, Xiubao Ren · 2016 · Advances in experimental medicine and biology
  50. Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand
    Charles T. Spencer, Pavlo Gilchuk, Srdan M. Dragovic, Sebastian Joyce · 2010 · Current Opinion in Organ Transplantation
  51. Adoptive T-cell Therapy: A Need for Standard Immune Monitoring
    Yarne Klaver, André Kunert, Stefan Sleijfer, Reno Debets, Cor HJ Lamers · 2015 · Immunotherapy
  52. MHC Multimer: A Molecular Toolbox for Immunologists
    Jun Chang · 2021 · Molecules and Cells
  53. Deep Profiling Human T Cell Heterogeneity by Mass Cytometry
    Y. Cheng, Evan William Newell · 2016 · Advances in immunology
  54. Production and Thermal Exchange of Conditional Peptide‐MHC I Multimers
    Jolien J. Luimstra, Kees L. M. C. Franken, Malgorzata Anna Garstka, Jan Wouter Drijfhout, Jacques Neefjes, Huib Ovaa · 2019 · Current Protocols in Immunology
  55. T cell receptor sequence clustering and antigen specificity
    Milena Vujović, Kristine Degn, Frederikke Isa Marin, Anna‐Lisa Schaap‐Johansen, Benny Chain, Thomas Lars Andresen, Joseph Kaplinsky, Paolo Marcatili · 2020 · Computational and Structural Biotechnology Journal
  56. Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)
    Beatrice Cavalluzzo, Marie Christine Viuff, Siri Amanda Tvingsholm, Concetta Ragone, Carmen Manolio, Angela Mauriello, Franco M. Buonaguro, Maria Lina Tornesello, Francesco Izzo, Alessandro Morabito et al. · 2024 · Journal of Experimental & Clinical Cancer Research
  57. Breadth and Dynamics of HLA-A2– and HLA-B7–Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection
    Margit H. Lampen, Hannes Uchtenhagen, Kim G. Blom, Renata Varnaitė, Jolita Pakalnienė, Laura Dailidyte, Sébastien Wälchli, Lars Lindquist, Auksė Mickienė, Jakob Michaëlsson et al. · 2018 · ImmunoHorizons
  58. TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
    Siri Amanda Tvingsholm, Marcus Svensson, Vibeke Mindahl Rafa, Ulla Kring Hansen, Maria Ormhøj, Alexander Tyron, Agnete W.P. Jensen, Mohammad Kadivar, Amalie Kai Bentzen, Kamilla Kjærgaard Munk et al. · 2023 · Journal for ImmunoTherapy of Cancer
  59. Simultaneous analysis of pMHC binding and reactivity unveils virus-specific CD8 T cell immunity to a concise epitope set
    Nikolaj Pagh Kristensen, Edoardo Dionisio, Amalie Kai Bentzen, Tripti Tamhane, Janine Sophie Kemming, Grigorii Nos, Lasse Frank Voss, Ulla Kring Hansen, Georg M. Lauer, Sine Reker Hadrup · 2024 · Science Advances
  60. Targeted agents for the treatment of metastatic melanoma
    Janet Ellen Dancey, Monzon · 2012 · OncoTargets and Therapy
  61. HLA Micropolymorphisms Strongly Affect Peptide–MHC Multimer–Based Monitoring of Antigen-Specific CD8+ T Cell Responses
    Marit M. van Buuren, Feline E. Dijkgraaf, Carsten Linnemann, Mireille Toebes, Cynthia Xin Lei Chang, Juk Yee Mok, Mélanie Nguyen, Wim J.E. van Esch, Pia Kvistborg, Gijsbert Marnix Grotenbreg et al. · 2013 · The Journal of Immunology
  62. A new mechanism shapes the naïve CD8+ T cell repertoire: the selection for full diversity
    Pedro Gonçalves, Marco Ferrarini, Carmen Molina-Parı́s, Grant Lythe, Florence Vasseur, Annik Lim, Bénédita Rocha, Orly Azogui · 2017 · Molecular Immunology
  63. Automated Analysis of Flow Cytometry Data to Reduce Inter-Lab Variation in the Detection of Major Histocompatibility Complex Multimer-Binding T Cells
    Natasja Wulff Pedersen, P. Anoop Chandran, Qian Yu, Jonathan A. Rebhahn, Nadia Viborg, Mathilde Dalsgaard Hoff, Scott White, Alexandra J. Lee, Rick Stanton, Charlotte Halgreen et al. · 2017 · Frontiers in Immunology
  64. Design and validation of conditional ligands for HLA‐B *08:01, HLA‐B *15:01, HLA‐B *35:01, and HLA‐B *44:05
    Thomas Mørch Frøsig, Jiawei Yap, Tina Seremet, Rikke Lyngaa, Inge Marie Svane, Per thor Straten, Mirjam H.M. Heemskerk, Gijsbert Marnix Grotenbreg, Sine Reker Hadrup · 2015 · Cytometry Part A
  65. The Promised Land of Human Immunology
    Laura F. Su, Arnold S. Han, Helen Marie McGuire, David Furman, Evan William Newell, Mark M. Davis · 2013 · Cold Spring Harbor Symposia on Quantitative Biology
  66. IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15
    Rachel A. Burga, Bülent Arman Aksoy, Zheng Ao, Jeremy H. Tchaicha, Dhruv K. Sethi, Alonso Villasmil Ocando, Gauri S. Kulkarni, Scott Lajoie, Kyle D. Pedro, Jack Ryan Tremblay et al. · 2025 · Molecular Therapy
  67. Computation strategies and clinical applications in neoantigen discovery towards precision cancer immunotherapy
    Zhenchang Wang, Yu Gu, Xiao Sun, Hao Huang · 2025 · Biomarker Research
  68. Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients
    Susana Patricia Amaya Hernandez, Ditte Stampe Hersby, Kamilla Kjærgaard Munk, Tripti Tamhane, Darya Trubach, Maria Tagliamonte, Luigi Buonaguro, Anne Ortved Gang, Sine Reker Hadrup, Sunil Kumar Saini · 2023 · Frontiers in Immunology
  69. Multiplex peptide-MHC tetramer staining using mass cytometry for deep analysis of the influenza-specific T-cell response in mice
    Michael Fehlings, Svetoslav Chakarov, Yannick Simoni, B. Sivasankar, Florent Ginhoux, Evan William Newell · 2017 · Journal of Immunological Methods
  70. Tumor antigen discovery through translation of the cancer genome
    Michael Siavash Khodadoust, Ash A. Alizadeh · 2014 · Immunologic Research
  71. Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses
    Louise C. Rowntree, Thi H. O. Nguyen, Hanim Halim, Anthony Wayne Purcell, Jamie Rossjohn, Stéphanie Gras, Tom C. Kotsimbos, Nicole A. Mifsud · 2018 · The Journal of Immunology
  72. Multiplexed Peptide-MHC Tetramer Staining with Mass Cytometry
    Mei Ling Leong, Evan William Newell · 2015 · Methods in molecular biology
  73. Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants
    Andreas Svensson, Tove Sandberg, Peter Siesjö, Håkan Eriksson · 2017 · Immunologic Research
  74. DNA-Barcoded pMHC Tetramers for Detection of Single Antigen-Specific T Cells by Digital PCR
    Shreyas N. Dahotre, Yun Min Chang, Anna M. Romanov, Gabriel A. Kwong · 2019 · Analytical Chemistry
  75. TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors
    Maria Stadheim Eggebø, Julia Heinzelbecker, Heyilimu Palashati, Nicholas Chandler, Trung The Tran, Yingqian Li, Weiwen Yang, Maarja Laos, Isaac Blaas, Even Holth Rustad et al. · 2025 · Nature Immunology
  76. Benchmarking unsupervised methods for inferring TCR specificity
    2025
  77. Integrated process design for single‐cell analytical technologies
    John Christopher Love · 2010 · AIChE Journal
  78. The Tetramer Transformation
    Peter C. Doherty · 2011 · The Journal of Immunology
  79. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8+ T lymphocytes
    Sabine Tischer, Till F. Kaireit, Constança Figueiredo, Oliver Hiller, Britta Maecker‐Kolhoff, René Geyeregger, Stephan Immenschuh, Rainer Blasczyk, Britta Eiz‐Vesper · 2012 · International Immunology
  80. Validation of Immunomonitoring Methods for Application in Clinical Studies: The HLA‐Peptide Multimer Staining Assay
    P. Anoop Chandran, Karoline Laske, Angelica M. Cazaly, Elisa Rusch, B Schmid-Horch, Hans‐Georg Rammensee, Christian H. H. Ottensmeier, Cécile Gouttefangeas · 2016 · Cytometry Part B Clinical Cytometry
  81. High-Dimensional Profiling of Tumor-Specific Immune Responses: Asking T Cells about What They “See” in Cancer
    Evan William Newell, Étienne Becht · 2018 · Cancer Immunology Research
  82. Individually addressable and dynamic DNA gates for multiplexed cell sorting
    Shreyas N. Dahotre, Daniel Y. Chang, Andreas Wieland, Samantha R. Stammen, Gabriel A. Kwong · 2018 · Proceedings of the National Academy of Sciences
  83. Recurrent bladder cancer in aging societies: Importance of major histocompatibility complex class I antigen presentation
    Edyta Wieczorek, Malgorzata Anna Garstka · 2020 · International Journal of Cancer
  84. Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy
    Ravi K. Shah, Erin E. Cygan, Tanya Kozlik, Alfredo S. Colina, Anthony Elston Zamora · 2023 · Frontiers in Immunology
  85. The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
    Michael V. Martin, Salvador Aguilar-Rosas, Katka Franke, Mark Pieterse, Jamie van Langelaar, Renée Schreurs, Maarten F. Bijlsma, Marc G. Besselink, Jan Köster, Wim Timens et al. · 2024 · Cancer Immunology Research
  86. optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input Material
    Mogjiborahman Salek, Jonas D. Förster, Jonas Philipp Becker, Marten Meyer, Pornpimol Charoentong, Yanhong Lyu, Katharina A.M. Lindner, Catharina Lotsch, Michael Volkmar, Frank Momburg et al. · 2024 · Molecular & Cellular Proteomics
  87. Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis
    Suzanne E. Brooks, Stephanie A. Bonney, Cindy Lee, Amy Publicover, Ghazala Naz Khan, Evelien Smits, Dagmar Sigurdardottir, Matthew J Arno, Demin Li, Ken Mills et al. · 2015 · PLoS ONE
  88. THE MAJOR HISTOCOMPATIBILITY COMPLEX: A REVIEW
    Preeti Sharma, Pradeep Kumar, Rachna Sharma · 2017 · Asian Journal of Pharmaceutical and Clinical Research
  89. Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer
    Apostolia Maria Tsimberidou, Kerstin Guenther, Börje S. Andersson, Regina Mendrzyk, Amir Alpert, Claudia Wagner, Anna Nowak, Katrin Aslan, Arun Satelli, Fabian Richter et al. · 2023 · Cancer Immunology Research
  90. Technologies for MHC class I immunoproteomics
    Rieuwert Hoppes, Reggy Ekkebus, Ton N. Schumacher, Huib Ovaa · 2010 · Journal of Proteomics
  91. Determining T-cell specificity to understand and treat disease
    Sine Reker Hadrup, Evan William Newell · 2017 · Nature Biomedical Engineering
  92. Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial
    S. Lot Aronson, Bram Thijssen, Marta López‐Yurda, Simone N. Koole, Paul van der Leest, Alicia León‐Castillo, Rolf Harkes, Iris M. Seignette, Joyce Sanders, Maartje Alkemade et al. · 2025 · Nature Communications
  93. A universal MHCII technology platform to characterize antigen-specific CD4+ T cells
    Rohit Vyasamneni, Victoria L. Kohler, Binisha Karki, Gauri Mahimkar, E. Esaulova, J. McGee, Daniel Kallin, J. Sheen, D. Harjanto, Miles Kirsch et al. · 2023 · Cell Reports Methods
  94. Reassessing human MHC-I genetic diversity in T cell studies
    Roderick C. Slieker, Daniël O. Warmerdam, Maarten H. Vermeer, Remco van Doorn, Mirjam H.M. Heemskerk, Ferenc A. Scheeren · 2024 · Scientific Reports
  95. Immune correlates of melanoma survival in adoptive cell therapy
    Agnes Fermin, Peter A. Sieling, Delphine J. Lee · 2013 · OncoImmunology
  96. Role of the MHC restriction during maturation of antigen‐specific human T cells in the thymus
    Leslie Hesnard, Francois P. Legoux, Laetitia Gautreau‐Rolland, Mélinda Moyon, Olivier Baron, Marie‐Claire Devilder, Marc Bonneville, Xavier Saulquin · 2015 · European Journal of Immunology
  97. Expression of the embryological morphogen Nodal in stage III/IV melanoma
    Anna I. Hooijkaas, Jules Gadiot, Hester van Boven, Christian U. Blank · 2011 · Melanoma Research
  98. Novel Cellular Microarray Assay for Profiling T-Cell Peptide Antigen Specificities
    Chaofang Yue, Mathias Oelke, Michael E. Paulaitis, Jonathan P. Schneck · 2010 · Journal of Proteome Research
  99. Multiplex Screening Assay for Identifying Cytotoxic CD8+ T Cell Epitopes
    Chek Meng Poh, Jian Hua Zheng, Rudragouda Channappanavar, Zi Wei Chang, Thi H. O. Nguyen, Laurent Rénia, Katherine Kedzierska, Stanley M. Perlman, Leo L. M. Poon · 2020 · Frontiers in Immunology
  100. The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer
    Janna R. Shapiro, Mario Corrado, Julie Ann Perry, Tania H. Watts, Shelly Bolotin · 2024 · Human Vaccines & Immunotherapeutics